These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6122919)

  • 21. The diagnosis and treatment of genital herpes.
    Corey L
    JAMA; 1982 Sep; 248(9):1041-9. PubMed ID: 7109193
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir].
    Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G
    Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Foscarnet-resistant herpes simplex virus infection in patients with AIDS.
    Safrin S; Kemmerly S; Plotkin B; Smith T; Weissbach N; De Veranez D; Phan LD; Cohn D
    J Infect Dis; 1994 Jan; 169(1):193-6. PubMed ID: 8277181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term suppressive therapy with acyclovir for recurrent genital herpes.
    Baker DA
    J Int Med Res; 1994; 22 Suppl 1():24A-31A; discussion 31A-32A. PubMed ID: 8063021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
    Chatis PA; Miller CH; Schrager LE; Crumpacker CS
    N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of long-term, low-dose acyclovir suppressive therapy on susceptibility to acyclovir and frequency of acyclovir resistance of herpes simplex virus type 2.
    Honda M; Okuda T; Hasegawa T; Kurokawa M; Shiraki K; Matsuo K; Komatsuzaki M; Niimura M
    Antivir Chem Chemother; 2001 Jul; 12(4):233-9. PubMed ID: 11771732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acyclovir-resistant Herpes simplex viruses in HIV-infected patients].
    Baumann R; Wunderli W; Riess C; Vogt M
    Schweiz Med Wochenschr; 1993 Dec; 123(51-52):2394-400. PubMed ID: 8290931
    [No Abstract]   [Full Text] [Related]  

  • 29. [Repeated antiviral therapy with acyclovir does not cause resistance].
    Svennerholm B; Löwhagen GB; Vahlne A; Lycke E
    Lakartidningen; 1987 Oct; 84(42):3387-90. PubMed ID: 3316881
    [No Abstract]   [Full Text] [Related]  

  • 30. Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.
    Richards DM; Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Nov; 26(5):378-438. PubMed ID: 6315332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A rapid screen test for in vitro susceptibility of clinical herpes simplex virus isolates.
    Safrin S; Elbeik T; Mills J
    J Infect Dis; 1994 Apr; 169(4):879-82. PubMed ID: 8133105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with acyclovir of genital herpes simplex virus infection complicated by eczema herpeticum.
    Robinson GE; Underhill GS; Forster GE; Kennedy C; McLean K
    Br J Vener Dis; 1984 Aug; 60(4):241-2. PubMed ID: 6744011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Virostatic treatment of herpes simplex infections of variable severity].
    Raab R; Söltz-Szöts J
    Hautarzt; 1990 Aug; 41(8):413-5. PubMed ID: 2272824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity of HSV strains isolated before and after treatment with acyclovir.
    Svennerholm B; Vahlne A; Löwhagen GB; Widell A; Lycke E
    Scand J Infect Dis Suppl; 1985; 47():149-54. PubMed ID: 3006229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acyclovir for intravenous use. Committee on Infectious Diseases and Immunization, Canadian Paediatric Society.
    Can Med Assoc J; 1984 Nov; 131(9):1045-6. PubMed ID: 6093977
    [No Abstract]   [Full Text] [Related]  

  • 36. Genital herpes: oral treatment with acyclovir.
    Ruhnek-Forsbeck M
    Scand J Infect Dis Suppl; 1985; 47():63-6. PubMed ID: 3912973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Herpes simplex virus infections in the neonatal period treated with acyclovir].
    Flaegstad T; Kolmannskog S; Vorland L
    Tidsskr Nor Laegeforen; 1984 Feb; 104(4):223-4. PubMed ID: 6322379
    [No Abstract]   [Full Text] [Related]  

  • 38. Oral acyclovir for treatment and suppression of genital herpes simplex virus infection. A review.
    Guinan ME
    JAMA; 1986 Apr; 255(13):1747-9. PubMed ID: 3512870
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of genital herpes simplex infections.
    Thin RN
    Am J Med; 1988 Aug; 85(2A):3-6. PubMed ID: 3407675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
    Pechère M; Wunderli W; Trellu-Toutous L; Harms M; Saura JH; Krischer J
    Dermatology; 1998; 197(3):278-80. PubMed ID: 9812037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.